[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Landolfi et al., 2021 - Google Patents

Machine learning approaches in Parkinson's disease

Landolfi et al., 2021

Document ID
14117116149083241460
Author
Landolfi A
Ricciardi C
Donisi L
Cesarelli G
Troisi J
Vitale C
Barone P
Amboni M
Publication year
Publication venue
Current medicinal chemistry

External Links

Snippet

Background: Parkinson's disease is the second most frequent neurodegenerative disorder. Its diagnosis is challenging and mainly relies on clinical aspects. At present, no biomarker is available to obtain a diagnosis of certainty in vivo. Objective: The present review aims at …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure

Similar Documents

Publication Publication Date Title
Landolfi et al. Machine learning approaches in Parkinson’s disease
Mei et al. Machine learning for the diagnosis of Parkinson's disease: a review of literature
Li et al. Applications of artificial intelligence to aid early detection of dementia: a scoping review on current capabilities and future directions
Navaneeth et al. PSO optimized 1-D CNN-SVM architecture for real-time detection and classification applications
Tagaris et al. Machine learning for neurodegenerative disorder diagnosis—survey of practices and launch of benchmark dataset
Chandrabhatla et al. Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson’s disease motor symptoms
Veeraragavan et al. Parkinson’s disease diagnosis and severity assessment using ground reaction forces and neural networks
Cavedoni et al. Digital biomarkers for the early detection of mild cognitive impairment: artificial intelligence meets virtual reality
Oung et al. Technologies for assessment of motor disorders in Parkinson’s disease: a review
Roth et al. Hidden Markov Model based stride segmentation on unsupervised free-living gait data in Parkinson’s disease patients
Sun et al. A novel deep learning approach for diagnosing Alzheimer's disease based on eye-tracking data
Skaramagkas et al. Multi-modal deep learning diagnosis of parkinson’s disease—A systematic review
Bo et al. IMU-based monitoring for assistive diagnosis and management of IoHT: a review
Khanna et al. Current challenges in detection of parkinson’s disease
Loaiza Duque et al. Using machine learning and accelerometry data for differential diagnosis of Parkinson’s disease and essential tremor
Ribeiro De Souza et al. A public data set of videos, inertial measurement unit, and clinical scales of freezing of gait in individuals with parkinson's disease during a turning-in-place task
Rastegarnia et al. Brain decoding of the Human Connectome Project tasks in a dense individual fMRI dataset
Skibińska et al. Parkinson’s disease detection based on changes of emotions during speech
Channa et al. Parkinson's disease resting tremor severity classification using machine learning with resampling techniques
Pateria et al. A comprehensive review on detection and classification of dementia using neuroimaging and machine learning
Hao et al. An automated digital biomarker of mobility
Pedrero-Sánchez et al. Classification of Parkinson's disease stages with a two-stage deep neural network
Faouzi et al. Machine learning for Parkinson’s disease and related disorders
Mikhalskii et al. Application of data analysis methods in research of neurodegenerative diseases
Divya et al. SUVR quantification using attention-based 3D CNN with longitudinal Florbetapir PET images in Alzheimer’s disease